系统性葡萄糖皮质类固醇对亚托皮性皮炎的使用和相关危害:索赔数据分析
Kristina Hagenström1, Theresa Klinger1, Katharina Müller1
1Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
The British journal of dermatology
|June 26, 2024
概括
在德国,系统性葡萄糖皮质类固醇 (SGC) 经常被长期处方用于治疗阿托皮性皮炎 (AD). 频繁使用SGC显著增加患骨质疏松症和糖尿病等严重健康状况的风险.
科学领域:
- 皮肤病学 皮肤病学
- 药物监督 药物监督 药物监督
- 医疗保健服务研究 医疗服务研究
背景情况:
- 系统性葡萄糖皮质类固醇 (SGCs) 是常见的短期的亚托皮性皮炎 (AD) 治疗.
- 由于严重的副作用风险,不建议长期使用SGC.
研究的目的:
- 分析德国法定医疗保险 (SHI) 中SGC利用模式,分析阿兹海默症患者的索赔数据.
- 调查SGC使用与阿兹海默症患者潜在有害副作用之间的关联.
主要方法:
- 德国大型SHI索赔数据集的横截面和纵向分析.
- 按处方季度和定义的每日剂量 (DDD) 量化SGC使用.
- 根据年龄,性别和发病率进行调整的分析.
主要成果:
- 2020年AD患病率为4.07%,其中9.91%的AD患者接受SGCs.
- 长期的SGC处方 (>1季度) 是常见的 (58%),其中15%的人接受了>6季度.
- 经常使用SGC观察到骨质疏松症 (OR 1.80-3.90) 和糖尿病 (OR 1.38-1.90) 的几率增加.
结论:
- 在德国,很大一部分AD患者长期接受SGCs.
- 频繁的SGC处方与已知的类固醇相关不良健康结果的更高发病率有关.
- 需要优化医疗保健策略,以减轻与AD长期使用SGC相关的风险.
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
236
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
236
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
115
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
115
Hypersensitivities
580
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
580
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
156
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
156
Drugs Used in Lower Respiratory Disorders: Overview
402
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
402
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
270
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
270


